Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1605
+0.0071 (4.63%)
At close: Aug 28, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $66.49 million as of August 28, 2026. Its market cap has decreased by -59.07% in one year.
Market Cap
66.49M
Enterprise Value
58.24M
Revenue
34.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 66.49M, a decrease of -28.01%. That is a compound annual growth rate of -1.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 66.49M | -52.95% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 121.82M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 89.42M |
| Nuo Therapeutics | 53.28M |
| Arch Biopartners | 50.95M |
| Vicapsys Life Sciences | 46.94M |
| Cell Source | 39.34M |
| BetterLife Pharma | 38.45M |